Literature DB >> 19706227

Etiologic aspects and prognostic factors of patients with chronic urticaria: nonrandomized, prospective, descriptive study.

Stamatis Gregoriou1, Dimitrios Rigopoulos, Andreas Katsambas, Alexandra Katsarou, Dimitrios Papaioannou, Aikaterini Gkouvi, George Kontochristopoulos, Ifigenia Danopoulou, Nikolaos Stavrianeas, Dimitris Kalogeromitros.   

Abstract

BACKGROUND: Studies investigating etiologic factors in chronic urticaria are based on small populations of a few hundred patients. In addition, data on prognostic factors of the disorder are scarce.
OBJECTIVE: To investigate the etiologic and prognostic factors of chronic urticaria on a large population referred to tertiary specialized hospital departments.
METHODS: The study investigated 2,523 patients with chronic urticaria and a negative autologous serum skin test using anamnesis, and the literature suggested laboratory tests for etiologic factors of the disorder. The patients were prescribed cetirizine 10 mg daily plus treatment of any underlying disorders illuminated by the laboratory investigation. The rescue medicine was loratadine 10 mg. The patients were evaluated every 3 months. Comparative statistical methods were used to evaluate the prognostic factors having an impact on the duration of the disorder until resolution of symptoms.
RESULTS: Etiologic factors of chronic urticaria-angioedema were identified in 38.7% of the patients. Physical urticarias had a prevalence of 17.1% in the population under study. Other common etiologic factors identified included infection (7.7%) and autoimmune thyropathy (7.3%). Multiple regression analysis showed that female gender, long duration of the disorder at the initial examination, the presence of angioedema, and physical urticarias are associated with worse prognosis of the disorder, whereas increased self-reported stress and psychiatric disease had no impact on the course of the disorder.
CONCLUSION: A detailed medical history and selective laboratory tests can illuminate etiologic factors in less than 40% of patients with chronic urticaria. Prognostic factors identified to impact the natural history of the disorder could be helpful when designing studies assessing the efficacy of therapeutic agents for chronic urticaria.

Entities:  

Mesh:

Year:  2009        PMID: 19706227     DOI: 10.2310/7750.2008.08035

Source DB:  PubMed          Journal:  J Cutan Med Surg        ISSN: 1203-4754            Impact factor:   2.092


  9 in total

1.  Investigation of patient-specific characteristics associated with treatment outcomes for chronic urticaria.

Authors:  Priyal Amin; Linda Levin; Sarah J Holmes; Jillian Picard; Jonathan A Bernstein
Journal:  J Allergy Clin Immunol Pract       Date:  2015-02-11

2.  A Comprehensive Approach to Urticaria: From Clinical Presentation to Modern Biological Treatments Through Pathogenesis.

Authors:  Marco Folci; Giacomo Ramponi; Enrico Brunetta
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Spinal radiographic progression over 2 years in ankylosing spondylitis patients treated with secukinumab: a historical cohort comparison.

Authors:  J Braun; H Haibel; M de Hooge; R Landewé; M Rudwaleit; T Fox; A Readie; H B Richards; B Porter; R Martin; D Poddubnyy; J Sieper; D van der Heijde
Journal:  Arthritis Res Ther       Date:  2019-06-07       Impact factor: 5.156

Review 4.  Psychiatric comorbidity in chronic urticaria patients: a systematic review and meta-analysis.

Authors:  Gerasimos N Konstantinou; George N Konstantinou
Journal:  Clin Transl Allergy       Date:  2019-08-23       Impact factor: 5.871

5.  Biomarkers In Chronic Spontaneous Urticaria: Current Targets And Clinical Implications.

Authors:  Ilaria Puxeddu; Fiorella Petrelli; Francesca Angelotti; Cristina Croia; Paola Migliorini
Journal:  J Asthma Allergy       Date:  2019-09-20

6.  Clustering the Clinical Course of Chronic Urticaria Using a Longitudinal Database: Effects on Urticaria Remission.

Authors:  Young Min Ye; Jiwon Yoon; Seong Dae Woo; Jae Hyuk Jang; Youngsoo Lee; Hyun Young Lee; Yoo Seob Shin; Dong Ho Nahm; Hae Sim Park
Journal:  Allergy Asthma Immunol Res       Date:  2021-05       Impact factor: 5.764

Review 7.  Urticaria in Pregnancy and Lactation.

Authors:  Emek Kocatürk; Indrashis Podder; Ana C Zenclussen; Alicja Kasperska Zajac; Daniel Elieh-Ali-Komi; Martin K Church; Marcus Maurer
Journal:  Front Allergy       Date:  2022-07-07

8.  Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?

Authors:  Emek Kocatürk; Emel Bülbül Başkan; Özlem Su Küçük; Mustafa Özdemir; Sinem Örnek; Pelin Kuteyla Can; Eda Haşal; Burhan Engin; Nilgün Atakan; Erkan Alpsoy
Journal:  An Bras Dermatol       Date:  2022-07-16       Impact factor: 2.113

9.  Sense of alexithymia in patients with anxiety disorders comorbid with recurrent urticaria.

Authors:  Ewa A Ogłodek; Anna M Szota; Marek J Just; Aleksander Araszkiewicz; Adam R Szromek
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-21       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.